Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Updates the displayed site revision/version indicator from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T06:29:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:27.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:23.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    - Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:49.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older revision notices (v3.4.1) were removed, along with a government funding status notice; these are site housekeeping changes that do not alter the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T11:47:51.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Administrative updates were added: a government funding notice and revision to v3.4.1 replacing v3.4.0, which do not affect core trial content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:38:54.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.